Animal Testing And Non-Animal Alternative Testing Market Outlook 2025-2035 - Featuring Profiles Of Charles River Laboratories, Labcorp, And Eurofins Scientific
Dublin, Aug. 27, 2026 (GLOBE NEWSWIRE) -- The "Animal Testing and Non-Animal Alternative Testing Global Market Opportunities and Strategies to 2035" has been added to ResearchAndMarkets.com's offering.
The latest animal testing and non-animal alternative testing market report provides a comprehensive analysis of industry performance from 2020 to 2025 and forecasts market growth through 2030 and 2035. The research examines global and regional market dynamics, major economies, emerging testing technologies, end-user demand and evolving regulatory requirements.
The global animal testing and non-animal alternative testing market reached approximately $15.19 billion in 2025, expanding at a compound annual growth rate (CAGR) of 4.1% from 2020. The market is projected to increase to $18.90 billion by 2030 at a CAGR of 4.5%. Continued growth at a CAGR of 4% between 2030 and 2035 is expected to take the global market value to $23.01 billion.
Historic market growth was supported by rising pharmaceutical research and development expenditure, the increasing prevalence of chronic diseases, stricter safety-testing requirements and the expanding global burden of infectious diseases. However, high initial investment requirements, ethical concerns and animal welfare activism placed constraints on market expansion during the period.
Looking ahead, growth will be driven by the expanding biopharmaceutical industry, an increasing number of drug discovery programs, greater demand for chemical and cosmetic safety testing and a stronger focus on drug safety validation. Potential market challenges include the limited availability of standardized animal models for certain diseases, stringent laboratory inspection and compliance requirements, and disruption associated with trade conflicts and tariffs.
Key animal testing and non-animal alternative testing market trends include advances in biotechnology, genomics and precision medicine. Artificial intelligence, autonomous systems, digitalization, cloud computing, big data and cybersecurity are also influencing research processes and testing platforms. Additional developments include connected laboratory ecosystems, smart infrastructure, sustainability initiatives, climate technology and circular-economy practices.
By type, the market is divided into animal testing and non-animal alternative testing. Animal testing remained the largest segment in 2025, accounting for 80.1% of the total market, or approximately $12.17 billion. Non-animal alternative testing is forecast to record the fastest growth from 2025 to 2030, achieving a CAGR of 6.3% as investment in advanced testing platforms and ethical research methods increases.
The animal testing segment covers mice, rats, frogs, fish, birds, guinea pigs, hamsters, rabbits, sheep, dogs, cats, monkeys, pigs and other animal types. Other animal types represented the largest subsegment in 2025, accounting for 14.7% of the animal testing market, or approximately $1.78 billion. Rat-based testing is expected to be the fastest-growing subsegment through 2030, with a projected CAGR of 5.7%.
By end-user application, the market includes the cosmetics, pharmaceutical and medical device industries, along with other applications. The pharmaceutical industry led the market in 2025 with a 50.1% share, valued at approximately $7.60 billion. Other end-user applications are expected to expand at the fastest rate between 2025 and 2030, recording a CAGR of 5.4%.
Industrial applications include basic research, applied research, regulatory testing, the development of new diagnostic methods, the breeding of genetically altered animals and animal cloning. Regulatory testing was the largest application segment in 2025, representing 26.6% of the market and generating approximately $4.04 billion. The breeding of genetically altered animals is forecast to be the fastest-growing application through 2030, with a CAGR of 6%.
North America was the largest regional animal testing and non-animal alternative testing market in 2025, accounting for 38.6% of global revenue, or approximately $5.87 billion. Western Europe and Asia-Pacific followed North America in market size. Asia-Pacific is forecast to be the fastest-growing region from 2025 to 2030, with a CAGR of 5.1%, followed by the Middle East at 4.8%. Africa and Eastern Europe are projected to grow at CAGRs of 4.7% and 4.5%, respectively.
Markets Covered:
1) By Type: Animal Testing; Non-Animal Alternative Testing
2) By End User Application: Cosmetics Industry; Pharmaceutical Industry; Medical Device Industry; Other End-User Applications
3) By End Use Industrial Application: Basic Research; Applied Research; Regulatory Testing; Development Of New Diagnostic Methods; Breeding Of Genetically Altered Animals; Animal Cloning
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; animal testing and non-animal alternative testing indicators comparison.
Data Segmentation: Country and regional historic and forecast data; market share of competitors; market segments.
Companies Featured
- Bio-Rad Laboratories Inc. SGS SA BioIVT Evotec SE CN Bio Innovations Ltd. Emulate Inc. Japan Tissue Engineering Co. Ltd. InSphero Charles River Laboratories TissUse GmbH Cortical Labs Invetus Pty Ltd Ozgene Pty Ltd WuXi AppTec Co., Ltd WuXi Biologics (Cayman) Inc Pharmaron Beijing Co., Ltd JOINN Laboratories (China) Co., Ltd PharmaLegacy Laboratories Co., Ltd Syngene International Limited Eurofins Advinus Limited Jubilant Biosys Limited Bioneeds India Private Limited Japan Tissue Engineering Co., Ltd LSI Medience Corporation CMIC Holdings Co., Ltd Shin Nippon Biomedical Laboratories, Ltd KAC Co., Ltd Biotoxtech Co., Ltd CorestemChemon Inc KNOTUS Co., Ltd CHA Biotech Co., Ltd BASF SE medac GmbH Chiron Corporation Pirbright Institute Queen Mary University of London Eurofins Scientific SE Intertek Group plc Tekro Ltd Selvita S.A SGS Romania Certara Emulate, Inc Quantiphi MatTek Corporation Promega Corporation Altasciences Company Inc ITR Laboratories Canada Inc Nucro-Technics Inc KGK Science Inc Biospective Inc Natura and Co Labcorp Holdings Inc SGS Peru S.A.C Pharmaseed Ltd Bioforum Group Bio-Rad Laboratories Inc SGS S.A
For more information about this report visit
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment